Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Aileens Pharma logo — Ride the Future

Aileens Pharma

Ride the Future

Founded 2018 Italy Italy 7 employees Series A Total: $3.00M Health Care, Pharmaceutical

General Information

Company Name Aileens Pharma
Founded Year 2018
Location Italy Italy +1
Founders / Decision Makers
Team member
Employees 7
Industries Health Care, Pharmaceutical
Funding Stage Series A
Social

Get notified when Aileens Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Aileens Pharma

Ailees Pharma is an Italian biotech company founded in June 2018, focusing on developing topical non-pharmacological and non-steroidal treatment for dermatological diseases. With the mission of providing the first topical treatment with a high safety and efficacy profile without the side effects of current pharmacological therapies, the company operates within the healthcare and pharmaceutical industries. Ailees Pharma recently received a €3.00M Series A investment from Panakes Partners on 25 July 2018 as it continues to progress in its efforts to revolutionize dermatological treatment. The company's headquarters is located in Italy.

Taxonomy: biotech firm, topical treatments, skin diseases, non-pharmacological solutions, non-steroidal treatments, atopic dermatitis, dermatological conditions, medication treatments, side effects, Italian biotech, funding, development, safety, innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 1
Investor
25 Jul 2018

Aileens Pharma Alternatives & Competitors

Aileens Pharma vs
2breathe Technologies Ltd.
2breathe Technologies Ltd. Israel

Harnessing the Therapeutic Power of Breathing

8 employees
Advertising, Information Technology
Aileens Pharma vs
Oculis
Oculis Switzerland

Oculis develops eye drops to treat ophthalmic diseases, improving patients' lives worldwide.

Post Ipo Equity
75 employees
Biotechnology, Health Care
Aileens Pharma vs
Hoba Therapeutics
Hoba Therapeutics Denmark

Developing Restorative Treatments for Chronic Neuropathic Pain and Hearing Loss

Series A
15 employees
Biotechnology, Health Care

FAQ About Aileens Pharma

Ride the Future
Aileens Pharma was founded in 2018.
Aileens Pharma is headquartered in Italy.
Aileens Pharma operates in the following industries: Health Care, Pharmaceutical.
Aileens Pharma has approximately 7 employees.
Aileens Pharma has completed 1 funding round, raising a total of $3.00M. The latest funding stage is Series A.
Top alternatives and competitors to Aileens Pharma include 2breathe Technologies Ltd., Oculis, Hoba Therapeutics, MediQuest Therapeutics, Dermapure. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aileens Pharma and 2breathe Technologies Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Aileens Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy